Edward Dulac
About Edward Dulac
Chief Financial Officer
Edward Dulac currently holds the position of Chief Financial Officer. In this role, he is responsible for managing the company's financial actions, including tracking cash flow and financial planning as well as analyzing the company's financial strengths and weaknesses. Dulac's background in finance and his strategic approach play a crucial role in ensuring the organization's fiscal health and future growth.
Vice President of Business Development & Strategy at Celgene
Before his current role, Edward Dulac served as Vice President of Business Development & Strategy at Celgene. His responsibilities involved developing and executing business strategies to drive growth and enhance market positioning. His work at Celgene included identifying new business opportunities, forming strategic partnerships, and leading initiatives to optimize business operations and expansion.
Biopharmaceutical Equity Research Analyst at Barclays Capital and Lehman Brothers
Edward Dulac has extensive experience in equity research, having worked as a biopharmaceutical equity research analyst at both Barclays Capital and Lehman Brothers. In these roles, he conducted in-depth research and analysis of biopharmaceutical companies, providing actionable insights and recommendations to investors. His expertise in financial analysis and market trends was pivotal in guiding investment decisions in the biopharmaceutical sector.
Corporate Finance at Pfizer
Edward Dulac also held a position in corporate finance at Pfizer, where he was involved in managing the company's financial strategies and planning. His work included budgeting, forecasting, and financial reporting, ensuring that the financial operations aligned with the organization's strategic goals. This role provided him with valuable experience in corporate financial management within a leading pharmaceutical company.
Education: B.S. in Pharmacy and M.B.A.
Edward Dulac received his B.S. in Pharmacy from the University of Pittsburgh, providing him with a strong foundation in pharmaceutical sciences. He furthered his education by earning an M.B.A. from the Kelley School of Business at Indiana University, where he deepened his knowledge of business administration and management. This combination of scientific and business education equips Dulac with a unique skill set advantageous in the biopharmaceutical and financial sectors.